Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus with Steroids vs Daclizumab in HCV Liver Transplant
NCT00295607Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2005
- Primary completion
- Jun 2008
- Modality
- RNA-Targeting Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of tacrolimus in hepatitis C (HCV), liver transplantation, sponsored by Astellas Pharma. Started Jun 2005; status: completed.
02
Drugs
tacrolimus
03
Conditions
hepatitis C (HCV)liver transplantation
Beyond the preview
Go deeper on NCT00295607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00295607.